Stock 4108 PHYTOHEALTH CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials PhytoHealth Corporation

Equities

4108

TW0004108006

Pharmaceuticals

End-of-day quote Taiwan S.E.
Other stock markets
 06:00:00 2024-05-02 pm EDT 		5-day change 1st Jan Change
20.2 TWD +0.75% Intraday chart for PhytoHealth Corporation +2.02% -6.91%
Feb. 27 PhytoHealth Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 23 PhytoHealth Corporation Signs MOU with Indena S.P.A. to Collaborate on Joint Development of Botanical Extracts for Phytohealth?s Research CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 2,961 2,945 4,140 4,628 3,794 4,310
Enterprise Value (EV) 1 2,066 2,206 3,397 3,244 2,463 3,072
P/E ratio -16.2 x -17.2 x -46.9 x -58.7 x -47.8 x -91.5 x
Yield - - - - - -
Capitalization / Revenue 27.6 x 30.8 x 45.1 x 27.4 x 28 x 26.5 x
EV / Revenue 19.2 x 23.1 x 37 x 19.2 x 18.2 x 18.9 x
EV / EBITDA -11.7 x -14.6 x -26.8 x -36 x -21.4 x -38.8 x
EV / FCF -14.5 x -28.8 x -33.1 x -50.5 x -55.5 x -52.5 x
FCF Yield -6.92% -3.47% -3.02% -1.98% -1.8% -1.9%
Price to Book 2.03 x 2.26 x 3.22 x 2.34 x 1.99 x 2.24 x
Nbr of stocks (in thousands) 163,616 163,616 163,619 198,619 198,619 198,619
Reference price 2 18.10 18.00 25.30 23.30 19.10 21.70
Announcement Date 2/27/19 3/2/20 2/25/21 2/23/22 3/1/23 2/27/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 107.5 95.48 91.81 168.9 135.5 162.5
EBITDA 1 -176.3 -150.7 -126.5 -90.16 -114.8 -79.16
EBIT 1 -230.2 -205.3 -170.4 -132.1 -156.7 -121.7
Operating Margin -214.18% -214.96% -185.64% -78.2% -115.65% -74.88%
Earnings before Tax (EBT) 1 -208.8 -204.8 -116.3 -95.52 -114.7 -74.15
Net income 1 -182.5 -170.8 -88.24 -77.72 -79.41 -47.12
Net margin -169.77% -178.83% -96.11% -46% -58.62% -29%
EPS 2 -1.115 -1.044 -0.5393 -0.3971 -0.3998 -0.2372
Free Cash Flow 1 -142.9 -76.61 -102.6 -64.28 -44.36 -58.46
FCF margin -132.99% -80.23% -111.72% -38.05% -32.75% -35.98%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/27/19 3/2/20 2/25/21 2/23/22 3/1/23 2/27/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 896 739 743 1,384 1,331 1,238
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -143 -76.6 -103 -64.3 -44.4 -58.5
ROE (net income / shareholders' equity) -10.4% -11.1% -6.87% -4.67% -4.92% -3.26%
ROA (Net income/ Total Assets) -6.75% -6.49% -5.77% -3.86% -4.05% -3.23%
Assets 1 2,702 2,629 1,529 2,014 1,961 1,461
Book Value Per Share 2 8.930 7.960 7.850 9.970 9.610 9.700
Cash Flow per Share 2 0.8300 0.6700 0.3700 0.4700 0.5100 0.3200
Capex 1 63.9 7.03 1.53 13.2 1.61 4.91
Capex / Sales 59.42% 7.37% 1.67% 7.82% 1.18% 3.02%
Announcement Date 2/27/19 3/2/20 2/25/21 2/23/22 3/1/23 2/27/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Biopharmaceuticals

1st Jan change Capi.
PHYTOHEALTH CORPORATION Stock PhytoHealth Corporation
-6.91% 124M
CSL LIMITED Stock CSL Limited
-3.79% 88.14B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+1.45% 40.51B
BIOGEN INC. Stock Biogen Inc.
-15.94% 31.67B
UCB Stock UCB
+52.66% 24.62B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-14.50% 15.65B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.97B
INCYTE CORPORATION Stock Incyte Corporation
-14.38% 12.07B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.81B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 4108 Stock
  4. Financials PhytoHealth Corporation